Conexeu Sciences, Inc. (CNXU)
3.06
-0.89
(-22.53%)
USD |
NASDAQ |
Oct 16, 16:00
3.31
+0.25
(+8.17%)
After-Hours: 20:00
Conexeu Sciences Research and Development Expense (Annual) : 0.4782M for Oct. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| October 31, 2025 | 0.4782M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vericel Corp. | 27.56M |
| AbbVie, Inc. | 8.249B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |